COPD

A generic drug-product combination for the treatment of asthma and COPD was just approved by the US Food and Drug Administration.

The FDA has approved a new option for the long-term maintenance treatment of airflow obstruction in individuals with chronic obstructive pulmonary disease.

The US Food and Drug Administration recently approved the first single dose once-daily inhaler to be used as maintenance therapy for patients with chronic obstructive pulmonary disease.

The FDA approved the first spirometer specifically developed for wireless home use for the monitoring of asthma, COPD, and other diseases.

The FDA has approved a drug already indicated for COPD treatment for the long-term, once-daily maintenance of asthma in individuals 12 years old and older.